{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:34:51Z","timestamp":1790710491279,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Traditional atrial fibrillation (AF) recurrence after catheter ablation is reported as a binary outcome. However, a paradigm shift towards a more granular definition, considering arrhythmic or symptomatic burden, is emerging. We hypothesize that ablation reduces AF burden independently of conventional recurrence status in patients with persistent AF, correlating with symptom burden reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Ninety-eight patients with persistent AF from the DECAAF II trial with pre-ablation follow-up were included. Patients recorded daily single-lead electrocardiogram (ECG) strips, defining AF burden as the proportion of AF days among total submitted ECG days. The primary outcome was atrial arrhythmia recurrence. The AF severity scale was administered pre-ablation and at 12 months post-ablation. At follow-up, 69 patients had atrial arrhythmia recurrence and 29 remained in sinus rhythm. These patients were categorized into a recurrence (n = 69) and a no-recurrence group (n = 29). Both groups had similar baseline characteristics, but recurrence patients were older (P = 0.005), had a higher prevalence of hyperlipidaemia (P = 0.007), and had a larger left atrial (LA) volume (P = 0.01). There was a reduction in AF burden in the recurrence group when compared with their pre-ablation burden (65 vs. 15%, P &amp;lt; 0.0001). Utah Stage 4 fibrosis and diabetes predicted less improvement in AF burden. The symptom severity score at 12 months post-ablation was significantly reduced compared with the pre-ablation score in the recurrence group, and there was a significant correlation between the reduction in symptom severity score and the reduction in AF burden (R = 0.39, P = 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Catheter ablation reduces AF burden, irrespective of arrhythmia recurrence post-procedure. There is a strong correlation between AF burden reduction and symptom improvement post-ablation. Notably, elevated LA fibrosis impedes AF burden decrease following catheter ablation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euae104","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T19:09:56Z","timestamp":1713467396000},"source":"Crossref","is-referenced-by-count":22,"title":["Comprehensive atrial fibrillation burden and symptom reduction post-ablation: insights from DECAAF II"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3179-4398","authenticated-orcid":false,"given":"Charbel","family":"Noujaim","sequence":"first","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-798X","authenticated-orcid":false,"given":"Ala","family":"Assaf","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-5601","authenticated-orcid":false,"given":"Chanho","family":"Lim","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-8931","authenticated-orcid":false,"given":"Han","family":"Feng","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7202-1164","authenticated-orcid":false,"given":"Hadi","family":"Younes","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5419","authenticated-orcid":false,"given":"Mario","family":"Mekhael","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-1590","authenticated-orcid":false,"given":"Nour","family":"Chouman","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaith","family":"Shamaileh","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4820-8102","authenticated-orcid":false,"given":"Abdel Hadi","family":"El Hajjar","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-1051","authenticated-orcid":false,"given":"Tarek","family":"Ayoub","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-2110","authenticated-orcid":false,"given":"Nino","family":"Isakadze","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Johns Hopkins University School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-1604","authenticated-orcid":false,"given":"Mihail G","family":"Chelu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine , Houston, TX , USA"},{"name":"Division of Cardiology, Baylor College of Medicine , Houston, TX , USA"},{"name":"Baylor St Luke\u2019s Medical Center , Houston, TX , USA"},{"name":"Texas Heart Institute , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-0541","authenticated-orcid":false,"given":"Nassir","family":"Marrouche","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-9061","authenticated-orcid":false,"given":"Eoin","family":"Donnellan","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery , 1430 Tulane Avenue, New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"2024053111022816400_euae104-B1","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"2024053111022816400_euae104-B2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"2024053111022816400_euae104-B3","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1001\/jama.2022.8831","article-title":"Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial","volume":"327","author":"Marrouche","year":"2022","journal-title":"JAMA"},{"key":"2024053111022816400_euae104-B4","doi-asserted-by":"crossref","DOI":"10.1177\/1179546820901508","article-title":"Smartphone ECG monitoring system helps lower emergency room and clinic visits in post-atrial fibrillation ablation patients","volume":"14","author":"Aljuaid","year":"2020","journal-title":"Clin Med Insights Cardiol"},{"key":"2024053111022816400_euae104-B5","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024053111022816400_euae104-B6","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"2024053111022816400_euae104-B7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2024053111022816400_euae104-B8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","article-title":"Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events","volume":"20","author":"Botto","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2024053111022816400_euae104-B9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2024053111022816400_euae104-B10","doi-asserted-by":"crossref","first-page":"euad173","DOI":"10.1093\/europace\/euad173","article-title":"Identifying the prognostic significance of early arrhythmia recurrence during the blanking period and the optimal blanking period duration: insights from the DECAAF II study","volume":"25","author":"Noujaim","year":"2023","journal-title":"Europace"},{"key":"2024053111022816400_euae104-B11","doi-asserted-by":"crossref","first-page":"e007559","DOI":"10.1161\/JAHA.117.007559","article-title":"Symptom burden of atrial fibrillation and its relation to interventions and outcome in Europe","volume":"7","author":"Schnabel","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024053111022816400_euae104-B12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/europace\/eus284","article-title":"Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients","volume":"15","author":"Herc\u00e9","year":"2013","journal-title":"Europace"},{"key":"2024053111022816400_euae104-B13","doi-asserted-by":"crossref","first-page":"e0226671","DOI":"10.1371\/journal.pone.0226671","article-title":"Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: a systematic review and economic evaluation","volume":"14","author":"Duarte","year":"2019","journal-title":"PLoS One"},{"key":"2024053111022816400_euae104-B14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41591-022-01979-w","article-title":"Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial","volume":"28","author":"Rizas","year":"2022","journal-title":"Nat Med"},{"key":"2024053111022816400_euae104-B15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15420\/aer.2021.01","article-title":"Impact of the pattern of atrial fibrillation on stroke risk and mortality","volume":"10","author":"Botto","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2024053111022816400_euae104-B16","doi-asserted-by":"crossref","first-page":"euad058","DOI":"10.1093\/europace\/euad058","article-title":"Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study","volume":"25","author":"van de Lande","year":"2023","journal-title":"Europace"},{"key":"2024053111022816400_euae104-B17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"2024053111022816400_euae104-B18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.116.021727","article-title":"Ablation of atrial fibrillation","volume":"134","author":"Link","year":"2016","journal-title":"Circulation"},{"key":"2024053111022816400_euae104-B19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2016.02.116","article-title":"Vagal response during pulmonary vein isolation: re-recognized its characteristics and implications in lone paroxysmal atrial fibrillation","volume":"211","author":"Qin","year":"2016","journal-title":"Int J Cardiol"},{"key":"2024053111022816400_euae104-B20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hrthm.2015.10.028","article-title":"Progression of atrial remodeling in patients with high-burden atrial fibrillation: implications for early ablative intervention","volume":"13","author":"Walters","year":"2016","journal-title":"Heart Rhythm"},{"key":"2024053111022816400_euae104-B21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.hrthm.2017.01.003","article-title":"Revisiting pulmonary vein isolation alone for persistent atrial fibrillation: a systematic review and meta-analysis","volume":"14","author":"Voskoboinik","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024053111022816400_euae104-B22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15420\/aer.2013.2.1.41","article-title":"Outcomes in women undergoing electrophysiological procedures","volume":"2","author":"Santangeli","year":"2013","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2024053111022816400_euae104-B23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2019.12.037","article-title":"Impact of type-2 diabetes mellitus on the outcomes of catheter ablation of atrial fibrillation (European Observational Multicentre Study)","volume":"125","author":"Creta","year":"2020","journal-title":"Am J Cardiol"},{"key":"2024053111022816400_euae104-B24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euae104\/57297678\/euae104.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/5\/euae104\/58012825\/euae104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/5\/euae104\/58012825\/euae104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T16:11:00Z","timestamp":1717171860000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae104\/7655712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae104","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,22]]},"article-number":"euae104"}}